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Reconstruction Practice
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Abstract
With medical advancement, increasing numbers of genetic variations and 
mutations are being uncovered that offer greater insight into which patients have 
a predisposition for the development of breast cancer. Reasonable management 
for these patients includes high-risk surveillance, medical prophylaxis, or bilateral 
prophylactic mastectomy with immediate reconstruction which is becoming 
increasingly popular. However, this cohort of patients differs from the average 
breast cancer patient in that they are typically younger and may have distinct 
reconstructive objectives for their outcomes. This chapter considers this unique 
and expanding population, as well as their expectations for surgical outcomes both 
aesthetically and oncologically. We will discuss the evolving role of social media in 
this population, with patient to patient virtual information sharing and how this 
may impact patient referrals in a manner diverging from traditional hospital-based 
patterns. Furthermore, we discuss how practices in which cutting-edge and novel 
surgical treatments are available, such as pre-pectoral and single stage reconstruc-
tion, and that incorporate team collaboration with the surgical oncologist to deliver 
aesthetically pleasing results with nipple sparing mastectomy and concealed scars 
may ultimately be attractive to genetic mutation carriers concerned not only with 
risk reduction but also post-operative aesthetics.
Keywords: bilateral prophylactic mastectomy, genetic mutation carriers, breast 
reconstruction, referrals, direct to implant reconstruction
1. Introduction
Primed with internet and social media, high risk breast cancer patients today 
are increasingly aware of potential outcomes, both oncologic and aesthetic. Modern 
surgeons today are adapting to an era of technology where patients are empow-
ered like never before. Patients are connected through online groups where they 
can support each other, share information regarding their treatment and discuss 
management well ahead of their surgical consultation. The era of the “simply 
grateful” patients has been replaced with an increasingly sophisticated generation 
of patients who can access information rapidly and network with other individuals 
facing similar decisions. Patients have the power to investigate, rate and review 
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their physicians and surgeons through online platforms, the results of which can 
have significant implications for a practitioner.
Considering the relative ease of obtaining information about surgical options 
coupled with patients’ growing self-awareness regarding their own health, the 
high-risk breast cancer patient population now confronts a myriad of surgical 
options. Decisions regarding bilateral prophylactic mastectomy (BPM) are being 
contemplated by high risk mutation carriers who wish to not only elude breast 
cancer’s grasp, but also remain physically attractive, feminine and desirable. In 
addition, awareness from prominent public figures and known mutation carriers, 
such as Angelina Jolie, has drawn admirers and critics alike for their decision to 
undergo BPM and reconstruction in the absence of cancer; surgeons must now 
adapt to a younger generation of patients with an elevated consciousness. A surgeon 
today must not only be constantly on top of the literature associated with breast 
cancer care, they must also evolve their practice to be cognizant that patients now 
may seek out their surgeons via less traditional methods. Online reviews, Facebook 
groups and virtual patient to patient interactions, which were once reserved for 
identifying high quality eating establishments, are now being used to distinguish 
high quality surgeons from a menu of practitioners. Physicians practicing in today’s 
medical environment can no longer rely solely on traditional methods of establish-
ing credibility such as pedigree, years of practice, and direct physician to physician 
recommendations. Google searches, medical review sites, online communities and 
social media can significantly impact a patient’s impression of MD integrity and 
excellence.
The genetic mutation carrier (GMC) female patient seeking risk reduction 
surgery with reconstruction is unique and we hope to elucidate how a surgeon 
can navigate their associated unique considerations and enhanced expectations, 
both aesthetic and oncologic. We will discuss the role of social media for patient-
to-patient virtual experience sharing, as well online physician review websites in 
regard to referral practices [1]. Furthermore, we will clarify what referral practices 
contributed to our institution’s recent surge in the GMC patient population. In 
addition, we will discuss optimal collaboration between the surgical oncologist and 
plastic surgeon needed to provide cutting-edge surgical treatment and novel surgi-
cal techniques such as prepectoral (above the muscle) and direct to implant (single 
stage) reconstruction, as well as how these practices may attract future patients.
2. Decisions facing a younger population of breast surgery patients
GMCs are an emerging population of patients with unique characteristics, per-
spective, and expectations of surgery. Only 1 out of every 400 people in the general 
population is estimated to be a BRCA1/2 mutation holder, with ~5–10% of breast 
cancers at all ages being associated with an inherited gene mutation [2]. Currently 
the BRCA1/2, ATM, CHEK2, PALB2, TP53, PTEN, CH1, STK11, NBN, NF1 muta-
tions all confer increased risk for breast cancer development, warranting the 
consideration of BPM for risk reduction [3]. Overall, we expect a 12% lifetime risk 
of breast cancer development in the general population without any risk factors [4]. 
This risk increases to 45–65% by age 70 in the population of known mutation carri-
ers of BRCA1/2 [2]. BPM has been shown to reduce the risk by roughly 90% in high 
risk populations [3], with prophylactic mastectomy and immediate reconstruction 
becoming increasingly more popular [5, 6]. However, not all GMCs choose BPM, 
some may prefer to elect chemoprophylaxis or high-risk surveillance instead. This 
decision is often determined by patient factors, with a recent study showing that 
GMCs choosing BPM over surveillance tend to have a college education, income 
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>$50,000, a first-degree relative with breast cancer, higher total number of relatives 
with breast cancer, and a prior pregnancy [7].
Frequently, woman does not receive a GMC status until after they are diagnosed 
with a cancer, generally at a younger age. Additionally, many are also being found 
prior to a cancer diagnosis because of a previously diagnosed family member that 
underwent that genetic work-up. With these avenues to diagnosis as a GMC, these 
patients are younger than the average breast cancer patient when they first see a 
surgeon. This younger age often plays a major role in the decisions these patients 
make regarding risk reduction surgery and reconstruction.
GMCs that elect for BPM and reconstruction tend to have higher aesthetic 
expectations than those who require the procedure for treatment of active cancer. 
There are multiple reasons for this, chief among them being that prophylactic sur-
gery is not considered ‘life-saving’ and that the patients are at a point in life where 
cosmesis may play a larger factor. The heightened concern for looking ‘natural’ and 
‘unoperated’ is an ongoing driver for novel surgical treatments when caring for a 
patient in this cohort.
In addition, unlike a breast cancer patient, GMC patients have the option of 
choosing when they want to undergo BPM. Certain life factors can greatly influ-
ence when a patient decides to ultimately undergo this prophylactic surgery in 
her lifetime. Large life events such as marriage and having children can be a major 
concern in this younger population. Additionally, bilateral mastectomies eliminate 
the possibility of a woman breastfeeding her children, which many women value 
as an important bonding experience between mother and child. Aspiring mothers 
considering BPM may not want to sacrifice this opportunity and timing will be an 
important factor. A GMC patient’s decision regarding surgical timing for BPM is 
completely personal, and ultimately weighs quality of life with the risk of breast 
cancer development during the delay. Thus, in a patient strongly desiring to breast-
feed her children, family planning plays a very important role in timing for BPM.
3. Long term considerations: implant longevity, surveillance
Yet another facet of caring for the younger age breast surgery patient popu-
lation is regarding the long-term durability of their reconstruction following 
BPM. Historically, it has been recommended that patients who underwent cosmetic 
breast augmentation have their implants exchanged approximately every 10 years. 
This was after a study published in 1995 found that 81% of implants studied at 
10 years were found to have been ruptured [8, 9]. However, due to advancements 
in implant technology resulting in increased stability of silicone implants using 
cohesive gel cross-linking technology and thicker implant shells, it is suggested that 
silicone implants today have greater longevity, but still are not considered ‘lifetime 
devices’. A patient can expect her implants to last at least a decade, with a 1% risk of 
rupture per year [10]. Another source estimates the new cohesive silicone implants 
to have a lifetime of 25–35 years [11]. Considering that women may be undergoing 
BPM with immediate reconstruction as early as their second and third decades 
of life, they would be expected to live another 50 or greater years following this 
surgery. Over this long of a timespan, a patient’s implants may experience signifi-
cant degradation, even considering new implant technology, with future surgery for 
replacement being considered by many an eventuality [10, 11].
It is important to remember that implant-based breast reconstruction comes 
with risk of prosthesis rupture, albeit minimal. Commonly, silicone implant rup-
ture is related to the normal aging of the prosthesis, but can also rarely be caused 
by forceful blunt trauma [11]. Implant rupture can occur both silently (without 
Breast Cancer and Breast Reconstruction
4
symptom development) or symptomatically, and is also classified as being intracap-
sular or extracapsular in nature. Intracapsular rupture is defined as being contained 
within the fibrous breast capsule, whereas extracapsular rupture is more concern-
ing and consists of extravasated silicone gel outside of the fibrous capsule into the 
surrounding tissues and can lead to inflammation and granuloma formation [11]. 
Extracapsular rupture is a rare occurrence with silicone implants [29], especially 
considering the high cohesive types used today. At this time, formal recommenda-
tions from the FDA include screening for silent rupture in patients with silicone 
implants using MRI at 3 years following prosthesis placement, and then every 
2 years thereafter [12]. However, a recent meeting of the advisory panel to the FDA 
released recommendations for revision in implant rupture screening guidelines 
in late March 2019. These updated recommendations consist of MRI screening at 
5–6 years post-operatively, and then every 2–3 years thereafter, with ultrasound 
being an acceptable alternative to MRI for screening in asymptomatic patients [13]. 
Unfortunately, these amendments are considered just panel recommendations 
to the FDA at this time, with the notion that they will be formally adopted by the 
agency in the upcoming months.
Another critical consideration in this patient population is that of continued 
surveillance following BPM and reconstruction. As discussed earlier, GMC patients 
need to be educated about the persistent need for surveillance despite prior mas-
tectomy. Patients should understand that although the majority of breast tissue is 
removed, the small amount left behind can still ultimately allow for cancer develop-
ment. Traditional surveillance with mammography is not an option following BPM 
with reconstruction, requiring this responsibility be placed on the patient and her 
physicians. Bearing this in mind, it is important for these patients to continue to 
follow with medical practitioners regularly. Furthermore, self-breast examination 
and awareness is encouraged to monitor for the formation of any new bumps or 
irregularities, as these could be cancer development from remnant breast tissue.
Considering all the long-term matters discussed above, it is essential for both the 
surgical oncologist and plastic surgeon to fully discuss these factors with prospec-
tive BPM and reconstruction patients. These factors may play important roles in the 
choice of those extremely adverse to further procedures, and may ultimately influ-
ence their decision regarding whether or not prophylactic surgery is the optimal 
way to manage their GMC status.
4. Prophylactic surgery and high expectations
Reconstructive expectations of breast cancer patients have evolved greatly over 
the past few decades with quality of life and survivorship becoming a central focus. 
This is especially true when treating GMCs, putting a greater demand on the surgi-
cal collaboration required for successful execution. Today, it is not uncommon for 
patients to expect their post-surgical breasts to improve their appearance and more 
closely match their desired size and shape than their pre-surgery breast aesthetic. 
Ultimately, the GMC patient has a choices regarding surgical timing, type and the 
decision to pursue surgery or not, so expectations are inherently high.
One reason for this rise may be the downstream effect of popular culture 
with increasing acceptance for a GMC’s surgical choices, normalizing the idea of 
having a bilateral mastectomy with reconstruction for risk reduction, while also 
demonstrating the fact that a woman can still be considered desirable and attrac-
tive after this surgery. Angelina Jolie, through a series of op-ed pieces written for 
the New York Times and other media outlets, recounted her personal journey with 
having the BRCA mutation, the passing of her mother from ovarian cancer, and 
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her surgical choices for BPM and reconstruction. She single-handedly has perhaps 
most profoundly affected public opinion regarding BPM and amplified awareness 
for a GMC’s breast cancer risk. Today, the modern GMC female interested in BPM 
expects she will retain her femininity and ability to identify as a beautiful woman 
post-operatively.
For the modern surgeon, it is important to convey a confident, but realistic 
depiction of the likely outcomes during the pre-operative consultation. This 
includes discussion of individual patient factors that can influence the final aes-
thetic outcome such as BMI, current breast size and ptosis, as well as the possibility 
of requiring revisional procedures in the future (e.g., fat grafting). Patients with 
realistic expectations of their reconstructive journey and cosmetic outcomes have 
been shown more likely to be satisfied with their BPM results. Additionally, it 
appears that patients who discuss BPM with their partners prior are more likely to 
be satisfied with intimacy post-operatively [14].
5. Online era: social media and patient influence
Social media plays an ever-expanding role in our lives. There are many online 
support groups for mutation carriers that easily and immediately connect patients 
around the world [15]. Within these online groups, and social media in general, 
now exists a special category of users referred to as ‘influencers’. These are users 
who cultivate a particularly large community of ‘followers’ with which they 
share experiences, ideas, products, and influence the general attitudes of those 
that follow them. It is not uncommon to see an individual sharing their entire 
experience as a ‘mutation carrier,’ ‘cancer thriver,’ or ‘cancer survivor’ on some 
form of social media (e.g., Instagram, Facebook, or a blog) [15]. This influence 
is not confined to the normal events of everyday life, but also extends to health 
decisions. Since the experiences of one person can be so easily disseminated, the 
clinical course and opinions of a single patient can disproportionally reverberate 
throughout the entire community. This process can act as an endorsement for, 
or dissuasion against, a certain treatment, surgery, or surgeon depending on the 
level of satisfaction of a single patient. This is particularly important to a surgeon’s 
referral-based practice as the large social media following of certain patients 
can have greater consequences, both good and bad, to their “business” than seen 
historically.
Moreover, online review sites for patients to publicly rate their physicians are 
becoming more and more prevalent. Patients are taking control over who they 
choose for their care, and this does not exclude surgeons. Many visit these web-
sites prior to committing their care to a certain surgeon, and use the information 
presented there to help guide their decision. Yet, an important question needs to 
be addressed: do the ratings on these websites actually correlate with the clinical 
outcomes achieved by the physicians? Recently this has become an area of intrigue 
in the surgical community, and over the past few years, a handful of small studies 
were published exploring the possible correlation between online health ratings 
of surgeons and their surgeon-specific measurable outcomes. Some of these 
investigated outcomes include infection rate, re-admission rate, revisional surgery 
rate, and risk-adjusted mortality rate, in surgeries such as total knee replacements, 
hernia repairs, and coronary artery bypass grafting. All of these studies failed 
to find any correlation between a surgeon’s online ratings and their measurable 
outcomes, including those listed above [16–18]. These results seriously undermine 
the utility of such websites, however are unlikely to be realized by the average 
health care consumer.
Breast Cancer and Breast Reconstruction
6
Furthermore, a similar study went one step further to try and identify what 
positively versus negatively influences a physician’s rating by reading and analyz-
ing the written reviews/comments on these websites. In order to accomplish this, 
the reviews were read by study staff and comments were classified as being either 
surgeon-dependent factors (competence or likeability) or surgeon-independent 
factors (office environment, staff, billing, etc.). Interestingly, this study found that 
comments on surgeon-dependent factors were associated with higher ratings, and 
furthermore that comments on surgeon-independent factors were associated with 
lower ratings [19]. This ultimately reinforces the results of the previously discussed 
studies, that physician ratings are not associated with outcomes, but rather highly 
influenced by office interactions. However, it does emphasize the importance of 
a good bedside manner for the surgeon, as well as his office staff, in addition to 
bringing awareness to the significance of the overall perceived patient experience 
when rating their physician on these websites—not unlike how a patron would 
consider their entire culinary dining experience and not just their food to formulate 
a restaurant review.
6. Our experience: what guides patient referrals
To better understand how the internet and social media affects patient referrals, 
we reviewed our patient database and identified recent GMCs in the absence of can-
cer (n = 10) that underwent BPM with immediate reconstruction at our institution. 
GMCs without a current diagnosis of cancer were of interest as they are inherently 
less pressured to make surgical decisions. Given these patients did not have active 
cancer, they had the advantage of taking as much time as they needed to research 
online, look for personal referrals, and read online health grade reviews before 
making their decision. Theoretically, they also had less tying them to a specific 
institution given no cancer diagnostic information had to be transferred from one 
institution to another. Patients’ referral patterns were reviewed and, if interested, 
were asked to complete a telephone survey (70% response rate) regarding their 
decision to pursue surgery at our institution.
Many stated that they first chose to undergo consultation at our institution 
because of internal referrals from physicians they already trusted. Most notably the 
patients stated their referrals tended to come from OB/GYNs when looking a surgi-
cal oncologist, and from the surgical oncologist when looking for a plastic surgeon. 
This emphasizes the importance of a strong collaborative relationship between the 
two surgeons.
The majority stated that the aspect of utmost importance in confirming their 
decision was feeling confident and comfortable with their surgeons after meeting 
them for initial consultations. Many women stated that their interactions with both 
the surgical oncologist and plastic surgeon were very open and honest, especially 
in taking the time to answer all the patients’ questions. They felt a strong personal 
connection with their surgeons and the warmth they experienced helped build 
trust, which comforted them and positively influenced their decision to receive care 
at our institution.
For many, the internet and social media served as a resource affirming their 
decision to receive care at our institution. One patient detailed that her surgical 
oncologist was mentioned favorably in Facebook groups, and plastic surgeon 
was known to have a great reputation online as well, but noted that this did not 
primarily drive her decision. Approximately one third of the patients looked at 
online health reviews and ratings for their surgeons prior to committing care to our 
institution, and stated again that these served to positively reinforce their decision.
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When asked about the most important factor regarding these surgeries, the 
majority of former patients stated that risk reduction was most important to them, 
however cosmetic outcomes were found to be almost equally as important. Younger 
patients appeared more concerned with cosmetic outcomes. In regard to novel 
surgical techniques attracting patients and influencing their decisions, most stated 
that the possibility of having single stage, also known as direct to implant (DTI), 
reconstruction was very appealing to them, and was sought out. Knowing that their 
plastic surgeon was a specialist in prepectoral DTI reconstruction was important 
to these women as well. However, not all were candidates for this option at initial 
consultation, but this fact did not dissuade their ultimate decision.
7. Novel reconstructive techniques: a patient attractor
We believe that in ultimately selecting a plastic surgeon for their breast recon-
structive needs, the modern GMC patient not only evaluates outcomes, but also 
considers surgeons performing state-of-the-art procedures, using the newest 
technologies and novel techniques, especially when they offer obvious advantages 
to the patient. This includes pre-pectoral implant placement, as well as single stage 
(also referred to as direct to implant (DTI)) reconstruction. Though not necessar-
ily actively sought out by all, the possibility of being able to have immediate single 
stage reconstruction could solidify a patient’s decision to receive care with a certain 
plastic surgeon by offering them the option of a shortened reconstructive course. 
More recently popularized mastectomy techniques such as the nipple sparring mas-
tectomy (NSM), when oncologically appropriate, are being more actively sought 
out from oncologic surgeons as well, as they also contribute to more aesthetically 
pleasing results.
The nipple is generally considered a distinguishing feature of a natural breast. 
Considering this fact, NSM continues to be increasingly popular with GMCs. In 
2018, a review of the American Society of Breast Surgeons (ASBrS) NSM database 
showed the majority of NSMs as being performed for prophylactic reasons [20]. 
Furthermore, NSM patients tend to be younger, Caucasian, and have smaller BMIs 
[21]. Another study showed higher body image scale scores in NSM compared to 
skin sparring mastectomy (SSM), but the difference was not statistically significant 
[22]. Other studies have also noted higher psychosocial [23] and sexual wellbeing 
scores in NSM patients [21].
However, NSM is not without risk; their documented complication rate is low 
but not insignificant, and includes possible complications to the nipple areolar 
complex (NAC) such as nipple necrosis and epidermolysis, in addition to infection 
and mastectomy flap necrosis risk seen in all mastectomies. A recent review of the 
ASBrS NSM database documented a NAC complication rate of 4.4% [20]. Moreover, 
there is a statistically significant decrease in the measured sensation of the NAC 
after NSM when compared to control groups [22]. Unfortunately, this reality of a 
nipple sparing mastectomy is not always completely understood by patients prior to 
consultation. Explaining these risks and realities can be more difficult in a patient 
population that has less tolerance for imperfection because of how it may affect 
their quality of life. Transparency and informed consent remain critical compo-
nents to counseling the GMC patient considering BPM.
New techniques in reconstructive surgery are also likely to influence a patient’s 
decision on their surgeon preference. Novel techniques available include the option 
for prepectoral implant placement, as well as single stage (direct to implant) 
reconstruction. The availability of these techniques to patients depends on several 
factors, the first of which being plastic surgeon’s experience with the procedures, 
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the patient’s current and desired final appearance, as well as mastectomy flap thick-
ness, perfusion and viability.
Two-stage breast reconstruction using tissue expanders placed subpectorally has 
been the traditional method for immediate breast reconstruction since the 1970s. 
This technique was developed during a time when mastectomies were more radical, 
excising more skin in the surgical process. Over time, the progression of mastecto-
mies from modified-radical to skin-sparring, and now nipple-sparing, has increased 
preservation of the breast envelope and allowed for reconstructive advancements 
as well. These larger breast envelopes create the option for placing implants at 
the initial surgery without placing excess tension on the mastectomy flaps. In 
properly chosen patients, this technique can be employed without an increased 
risk for complications [24]. Reconstructive surgery performed in two stages has 
drawbacks that DTI circumvents including the avoidance of multiple episodes of 
anesthesia [25–28]. Recent studies have also elucidated other possible advantages 
with DTI, including increased patient satisfaction, reduction in pain, and possible 
reduction in cost when comparing DTI with two stage reconstruction [25–27]. DTI 
reconstruction when first introduced capitalized on the safety and advantages of 
an expanded dual plane pocket using acellular dermal matrix (ADM) as an inferior 
sling to support implant placement under the pectoralis muscle in a single stage 
surgery [29, 30]. Despite the perceived benefits, DP DTI reconstructions still retain 
the same issues created by placing a prosthesis in the subpectoral or dual plane (DP) 
position, namely animation deformity and pectoralis major origin disruption caus-
ing weakened adduction [31].
Prepectoral (PP) implant placement resolved the issue of animation deformity 
caused by subpectoral placement [31, 32]. However, without routine use of ADM, 
the subcutaneous or prepectoral techniques were historically fraught with high 
rates of early capsular contracture [33], flap necrosis, implant loss [34], and 
concern for worsened aesthetics (e.g., implant visibility, rippling) often requiring 
additional procedures for revision such as fat grafting. One study compared PP 
placement with and without the use of ADM, demonstrating significantly lower 
rates of capsular contracture in the ADM cohort [35]. From our experience, the 
crucial components necessary for successful PP DTI include initial intraoperative 
assessment of flap perfusion with sizer in place, followed by the creation of a tight 
anterior ADM pocket for implant insertion [24]. Use of anterior ADM coverage 
for implant support and off-loading pressure on the mastectomy flaps prevents 
the complications traditionally associated with PP [24], while avoiding the disad-
vantages of DP placement. Despite this, the PP DTI technique has yet to be widely 
adopted secondary to the lingering concerns over historical complications and the 
steep learning curve.
Our group performed one of the largest DTI-only comparative study (n = 134) 
between outcomes of dual plane (DP) DTI and prepectoral (PP) DTI, and showed 
an overall low complication incidence, with PP DTI complications being slightly 
less frequent (PP 2% vs. DP 12%, p = 0.07). No implant losses were documented in 
this study. Furthermore, regarding the concern over increased need for aesthetic 
revisional procedures in PP patients, no difference was shown in the likelihood 
of either DP or PP DTI patients to undergo these additional procedures. Last, this 
study reinforced the positive aesthetic outcomes of PP DTI with a blinded panel 
scoring PP DTI reconstructions higher than DP DTI in terms of aesthetic outcome 
[32]. This study effectively corroborated the non-inferiority of PP DTI to DP DTI 
reconstructive techniques, as well as demonstrated its advantage in better cosmetic 
outcomes. Because of this, the ability to perform PP DTI could be potentially attrac-
tive to patients concerned with aesthetic outcomes when looking for a reconstruc-
tive surgeon.
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Finally, it should be noted that appropriate patient selection is of utmost impor-
tance for successful PP DTI. As explained earlier in this chapter, adequate mastec-
tomy flap perfusion is crucial for employment of this reconstructive technique, and 
we advocate intra-operative use of fluorescence imaging technology to ensure this. 
Our group considers active smoking and uncontrolled medical co-morbidities to be 
absolute contraindications to PP DTI. Whereas, obesity is only considered a relative 
contraindication and our group has found that the use of oncoplastic reconstructive 
techniques in conjunction with implant placement has yielded great results. More 
ideal patients for PP DTI include those desiring results similar to their native breast 
size [24], though we have found upsizing of the breast to be possible in the compli-
ant envelope.
8. Surgeon collaboration: oncologic and reconstructive considerations
The goal of BPM in GMCs is risk reduction, and in order to achieve this goal, 
removal of as much breast tissue as possible provides the best oncologic benefit. 
A mastectomy, while drastically reducing cancer occurrence, does not completely 
eliminate the possibility of breast cancer development in the future. As tissue 
removal and oncologic benefit increases, risk benefit must be considered as 
excessively thin mastectomy flaps incur higher risk for ischemia, complicating 
reconstructive efforts. Adequate flap vascularity is a critical component to success-
ful breast reconstruction, especially single stage, with thicker flaps conferring less 
risk of ischemia and flap necrosis [31, 36]. This relationship between removing the 
maximum amount of breast tissue while retaining flap perfusion are the competing 
priorities that surgical oncologists and plastic surgeons must navigate effectively 
together.
Approaching a combined mastectomy/reconstruction patient most importantly 
requires effective communication between the two surgeons. Additionally, in 
our institution we employ fluorescence imaging technology in immediate breast 
reconstruction cases to help quantify perfusion to the flaps [37]. This practice 
identifies the flaps at risk for ischemia so that the appropriate reconstructive path 
for each patient can be followed, guiding the decision-making process surround-
ing whether a patient is more appropriate for one or two stage reconstruction, or 
delayed reconstruction.
9. Conclusion
Overall, the improved understanding of genetic mutation and risk for breast 
cancer development has created a special population of breast surgery patients. 
They have specific priorities that must be considered when it comes to surgical 
planning, risk tolerance, long term considerations, and both oncologic and aesthetic 
outcomes. This population’s younger age may play a large role in expectations with 
higher value placed on cosmesis. In response, techniques such as NSM and single 
stage prepectoral reconstruction are being more commonly used to meet this popu-
lation’s particular demands for excellent outcomes, both oncologic and cosmetic.
Considering our modern online era, we believe that the internet and social 
media will continue to increasingly affect patient referral patterns. Although online 
rating and review websites so far have shown no correlation with a surgeon’s actual 
measurable outcomes, it appears as though they continue to be popular informa-
tion sources for prospective patients and help confirm their decisions on where to 
receive care. Being mindful of this online presence will be crucial for the successful 
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modern plastic surgery practice, in addition to offering novel surgical techniques 
to satisfy the expectations of today’s patients. However, the traditional practice of 
upholding a good bedside manner, developing excellent surgeon-patient rapport, 
and patient trust in their referring physician will continue to be important factors.
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